Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Various Commercially Available Face Coverings

Research Leaders

6 sponsors active, led by Guy's and St Thomas' NHS Foundation Trust

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed3
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Various Commercially Available Face Coverings1
  • Biocontainment Device For Aerosol Generating Procedures Biobox1
  • Control For Aerosol Generating Procedures1
  • Mouthpiece B1mouthpiece Mpcst Gmdn62534 Generic Name Endoscopic Bite Block Basic Reusable1
  • Not An Interventional Study1

Active Sponsors

  • Guy's and St Thomas' NHS Foundation Trust1
  • Massachusetts General Hospital1
  • Harvard School of Public Health (HSPH)1
  • Universitaire Ziekenhuizen KU Leuven1
  • University of Pennsylvania1

Top Investigators

Related Conditions

  • Protective Device Physical Object1
  • Lung Infection1
  • Aerosol Disease1
  • Respiratory Tract Infections1
  • Healthy1

Activity Timeline